{"id":"F2010L02062","name":"National Health Act 1953 - Determinations under sections 85, 85A and 88 - Pharmaceutical benefits (No. PB 68 of 2010)","slug":"national-health-act-1953-determinations-under-sections-85-85a-and-88-pharmaceutical-benefits-no-pb-6","collection":"legislative_instrument","jurisdiction":"commonwealth","status":"repealed","isInForce":false,"actNumber":null,"makingDate":null,"administeringDepartment":null,"currentVersion":{"id":124645,"registerId":"commonwealth-F2010L02062-current","compilationNumber":null,"startDate":"2026-04-03","status":"Repealed","reasons":null,"registeredAt":null},"sections":[{"sectionNumber":"SCHEDULE 1","sectionType":"schedule","heading":"PART 1","content":"## SCHEDULE 1 - PART 1","sortOrder":0},{"sectionNumber":"Listed Drug","sectionType":"schedule","heading":"Listed Drug","content":"## Listed Drug","sortOrder":1},{"sectionNumber":"Form","sectionType":"schedule","heading":"Form","content":"## Form\n\n## (strength, type, size, etc.)","sortOrder":2},{"sectionNumber":"(strength, type, size, etc.)","sectionType":"schedule","heading":"(strength, type, size, etc.)","content":"## Form\n\n## (strength, type, size, etc.)","sortOrder":3},{"sectionNumber":"Manner of adminis-","sectionType":"schedule","heading":"Manner of adminis-","content":"## Manner of adminis-\n\n## tration","sortOrder":4},{"sectionNumber":"tration","sectionType":"schedule","heading":"tration","content":"## Manner of adminis-\n\n## tration","sortOrder":5},{"sectionNumber":"Maximum quantity","sectionType":"schedule","heading":"Maximum quantity","content":"## Maximum quantity","sortOrder":6},{"sectionNumber":"Maximum number of repeats","sectionType":"schedule","heading":"Maximum number of repeats","content":"## Maximum number of repeats","sortOrder":7},{"sectionNumber":"Brand","sectionType":"schedule","heading":"Brand","content":"## Brand","sortOrder":8},{"sectionNumber":"Streamlined authority code","sectionType":"schedule","heading":"Streamlined authority code","content":"## Streamlined authority code","sortOrder":10},{"sectionNumber":"Purposes","sectionType":"schedule","heading":"Purposes","content":"## Purposes","sortOrder":11},{"sectionNumber":"Manner of adminis-tration","sectionType":"schedule","heading":"Manner of adminis-tration","content":"## Manner of adminis-tration","sortOrder":12},{"sectionNumber":"SCHEDULE 2","sectionType":"schedule","heading":"PART 1","content":"## SCHEDULE 2 - PART 1","sortOrder":14},{"sectionNumber":"SCHEDULE 3","sectionType":"schedule","heading":"PART 1","content":"## SCHEDULE 3 - PART 1","sortOrder":16},{"sectionNumber":"SCHEDULE 4","sectionType":"schedule","heading":null,"content":"## SCHEDULE 4","sortOrder":18},{"sectionNumber":"Form of Medicinal Preparation","sectionType":"schedule","heading":"Form of Medicinal Preparation","content":"## Form of Medicinal Preparation","sortOrder":19}],"analysis":{"kimi_summary":{"_metrics":{"model":"kimi-k2.5","source":"moonshot-batch","completionTokens":1427},"content_quality":"rejected","complexity_score":1,"rejection_reason":"The content is an incomplete fragment or stub consisting solely of column headers and schedule titles without any actual determinations, drug listings, or substantive legislative text required for meaningful analysis.","scope_assessment":{"changed":false,"description":"Document is an empty template with no legislative scope to assess."},"complexity_factors":["Document contains only template headers and column titles with no substantive legislative text","No defined terms, operative provisions, or regulatory conditions present","No cross-references to other sections of the Act or external instruments","No exceptions, limitations, or procedural requirements specified"],"plain_english_summary":"This document is an empty template or placeholder for a pharmaceutical benefits determination under the *National Health Act 1953*. It contains only structural headings and column titles—such as \"Listed Drug\", \"Form\", \"Manner of administration\", and \"Maximum quantity\"—organised into various schedules (Parts 1 and 2 of Schedules 1-3, and Schedule 4). **Crucially, it contains no actual substance**: no specific medications, no quantities, no brands, and no streamlined authority codes are listed. It appears to be a formatting framework or table structure awaiting population with actual data."}},"importantCases":[],"_links":{"self":"/api/acts/national-health-act-1953-determinations-under-sections-85-85a-and-88-pharmaceutical-benefits-no-pb-6","history":"/api/acts/national-health-act-1953-determinations-under-sections-85-85a-and-88-pharmaceutical-benefits-no-pb-6/history","analysis":"/api/acts/national-health-act-1953-determinations-under-sections-85-85a-and-88-pharmaceutical-benefits-no-pb-6/analysis","conflicts":"/api/acts/national-health-act-1953-determinations-under-sections-85-85a-and-88-pharmaceutical-benefits-no-pb-6/conflicts","importantCases":"/api/acts/national-health-act-1953-determinations-under-sections-85-85a-and-88-pharmaceutical-benefits-no-pb-6/important-cases","documents":"/api/acts/national-health-act-1953-determinations-under-sections-85-85a-and-88-pharmaceutical-benefits-no-pb-6/documents"}}